Auriga Partners and Kreaxi invest in Nosopharm
Client(s) Auriga Partners and Kreaxi
Jones Day represented Auriga Partners and Kreaxi in connection with their investment in Nosopharm, a France-based biotechnology company specialized in the research and development of new antimicrobial molecules. Alto Invest acted as co-investor in the investment round.